Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18637845rdf:typepubmed:Citationlld:pubmed
pubmed-article:18637845lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18637845lifeskim:mentionsumls-concept:C0151699lld:lifeskim
pubmed-article:18637845lifeskim:mentionsumls-concept:C0019116lld:lifeskim
pubmed-article:18637845lifeskim:mentionsumls-concept:C1744681lld:lifeskim
pubmed-article:18637845lifeskim:mentionsumls-concept:C0243067lld:lifeskim
pubmed-article:18637845pubmed:issue5lld:pubmed
pubmed-article:18637845pubmed:dateCreated2008-10-21lld:pubmed
pubmed-article:18637845pubmed:abstractTextWe investigated 52 of 457 patients with congenital factor deficiencies with 57 episodes of intracranial haemorrhage (ICH) between 1998 and 2007. There were 38 severe haemophiliacs, 6 with factor XIII deficiency, 5 with factor X deficiency, 2 factor V-deficient patients, and 1 with type 3 von Willebrand disease (VWD). The median age was 8 years (range 1 month-22 years). Most patients were below 15 years of age (86.5%). All patients with factor X deficiency were between 1 and 5 months of age. ICH was the primary bleeding episode leading to detection of factor deficiency in 19.2% (five patients with severe haemophilia and all patients with factor X deficiency). Trauma caused bleeding in 66%. None of the patients with factor X deficiency had history of prior trauma. Surgery was performed in five patients with subdural haematomas, all of whom survived. Conservative factor replacement with 100% correction for 3 days followed by 50-60% correction for 7 days was possible in 60% patients. Seizures requiring prolonged therapy were noted in eight patients. Death was recorded in 15 patients (29%). Inadequate therapy in the form of delay or insufficient replacement was noted in 7/15 deaths. ICH was seen in 11.3% of all patients with coagulation factor deficiencies. Factor X deficiency presented with ICH at an earlier age. Inadequate replacement therapy including delayed treatment caused nearly 50% of all deaths. Most patients can be managed satisfactorily with adequate replacement therapy alone, with surgery being reserved for those with worsening neurological conditions.lld:pubmed
pubmed-article:18637845pubmed:languageenglld:pubmed
pubmed-article:18637845pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18637845pubmed:citationSubsetIMlld:pubmed
pubmed-article:18637845pubmed:statusMEDLINElld:pubmed
pubmed-article:18637845pubmed:monthSeplld:pubmed
pubmed-article:18637845pubmed:issn1365-2516lld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:KumarRRlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:BhargavaRRlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:SaxenaRRlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:DhootB MBMlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:MishraPPlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:RADUE MEMlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:DolanSSlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:MahapatraMMlld:pubmed
pubmed-article:18637845pubmed:authorpubmed-author:NaithaniRRlld:pubmed
pubmed-article:18637845pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18637845pubmed:volume14lld:pubmed
pubmed-article:18637845pubmed:ownerNLMlld:pubmed
pubmed-article:18637845pubmed:authorsCompleteYlld:pubmed
pubmed-article:18637845pubmed:pagination952-5lld:pubmed
pubmed-article:18637845pubmed:dateRevised2009-10-21lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:meshHeadingpubmed-meshheading:18637845...lld:pubmed
pubmed-article:18637845pubmed:year2008lld:pubmed
pubmed-article:18637845pubmed:articleTitleIntracranial haemorrhage in patients with congenital haemostatic defects.lld:pubmed
pubmed-article:18637845pubmed:affiliationDepartment of Hematology, All India Institute of Medical Sciences, New Delhi, India. pravas_mishra@rediffmail.comlld:pubmed
pubmed-article:18637845pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18637845lld:pubmed